Ventyx Biosciences, Inc.
NASDAQ:VTYX
2.2 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -192.962 | -108.426 | -83.746 | -28.174 | -4.327 |
| Depreciation & Amortization
| 0.941 | 0.47 | 0.03 | 0 | 0 |
| Deferred Income Tax
| 0.745 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 28.588 | 16.57 | 2.73 | 0.045 | 0.198 |
| Change In Working Capital
| 5.806 | -5.157 | 4.016 | 0.812 | 0.591 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.745 | 1.613 | 2.443 | 0.591 | 0.361 |
| Other Working Capital
| 0.745 | -6.77 | 1.573 | 0.221 | 0.23 |
| Other Non Cash Items
| -9.64 | -2.228 | 38.32 | 21.122 | 0.896 |
| Operating Cash Flow
| -166.522 | -98.771 | -38.65 | -6.195 | -2.642 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.514 | -0.275 | -0.262 | 0 | 0 |
| Acquisitions Net
| -0.101 | 0.075 | 1.899 | 0 | 0 |
| Purchases Of Investments
| -272.271 | -347.236 | -232.502 | 0 | 0 |
| Sales Maturities Of Investments
| 373.725 | 272.58 | 16.5 | 0 | 0 |
| Other Investing Activites
| 0.101 | -0.075 | -0.216 | 0 | 0 |
| Investing Cash Flow
| 100.94 | -74.931 | -214.365 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -0.45 | -6.128 | -2.95 |
| Common Stock Issued
| 53.329 | 167.772 | 158.815 | 0.002 | 0.001 |
| Common Stock Repurchased
| 0.25 | 0.267 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 53.329 | 167.772 | 165.186 | 12.256 | 5.9 |
| Financing Cash Flow
| 53.329 | 167.772 | 323.551 | 6.13 | 2.951 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| -0.012 | -0.042 | 0.011 | 0 | 0 |
| Net Change In Cash
| -12.265 | -5.972 | 70.547 | -0.065 | 0.309 |
| Cash At End Of Period
| 52.554 | 64.819 | 70.791 | 0.244 | 0.309 |